BIOLIT ApS: Financial statements 2018
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,255,924 and a net result of DKK 953,640 compared with DKK 1,052,433 the year before. That is a decrease of 8.5% compared with the year before. Equity amounted to DKK 5,606,121. The solvency ratio was 60%.
- Gross Profit
- 1,255,924 kr.
- Profit/Loss
- 953,640 kr.
- Equity
- 5,606,121 kr.
- Total Assets
- 9,343,053 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
| 2017 | - | 1.4 mio. | 1.1 mio. | 4.7 mio. | - |
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
| 2015 | - | 1.1 mio. | 795 t. | 2.2 mio. | - |
| 2014 | - | 746 t. | 617 t. | 1.5 mio. | - |
Keep an eye on BIOLIT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
